222 related articles for article (PubMed ID: 10487677)
1. Oral glibenclamide suppresses glucagon secretion during insulin-induced hypoglycemia in patients with type 2 diabetes.
Landstedt-Hallin L; Adamson U; Lins PE
J Clin Endocrinol Metab; 1999 Sep; 84(9):3140-5. PubMed ID: 10487677
[TBL] [Abstract][Full Text] [Related]
2. Effects of glimepiride and glyburide on glucose counterregulation and recovery from hypoglycemia.
Szoke E; Gosmanov NR; Sinkin JC; Nihalani A; Fender AB; Cryer PE; Meyer C; Gerich JE
Metabolism; 2006 Jan; 55(1):78-83. PubMed ID: 16324923
[TBL] [Abstract][Full Text] [Related]
3. The use of tolbutamide-induced hypoglycemia to examine the intraislet role of insulin in mediating glucagon release in normal humans.
Peacey SR; Rostami-Hodjegan A; George E; Tucker GT; Heller SR
J Clin Endocrinol Metab; 1997 May; 82(5):1458-61. PubMed ID: 9141533
[TBL] [Abstract][Full Text] [Related]
4. Hormonal and metabolic counterregulation during and after high-dose insulin-induced hypoglycemia in diabetes mellitus type 2.
Bischof MG; Ludwig C; Hofer A; Kletter K; Krebs M; Stingl H; Nowotny P; Waldhäusl W; Roden M
Horm Metab Res; 2000 Oct; 32(10):417-23. PubMed ID: 11069207
[TBL] [Abstract][Full Text] [Related]
5. A prospective trial of risk factors for sulfonylurea-induced hypoglycemia in type 2 diabetes mellitus.
Burge MR; Schmitz-Fiorentino K; Fischette C; Qualls CR; Schade DS
JAMA; 1998 Jan; 279(2):137-43. PubMed ID: 9440664
[TBL] [Abstract][Full Text] [Related]
6. The dipeptidyl peptidase 4 inhibitor vildagliptin does not accentuate glibenclamide-induced hypoglycemia but reduces glucose-induced glucagon-like peptide 1 and gastric inhibitory polypeptide secretion.
El-Ouaghlidi A; Rehring E; Holst JJ; Schweizer A; Foley J; Holmes D; Nauck MA
J Clin Endocrinol Metab; 2007 Nov; 92(11):4165-71. PubMed ID: 17698900
[TBL] [Abstract][Full Text] [Related]
7. A high concentration of circulating insulin suppresses the glucagon response to hypoglycemia in normal man.
Liu D; Moberg E; Kollind M; Lins PE; Adamson U
J Clin Endocrinol Metab; 1991 Nov; 73(5):1123-8. PubMed ID: 1682339
[TBL] [Abstract][Full Text] [Related]
8. The effect of combination treatment with acarbose and glibenclamide on postprandial glucose and insulin profiles: additive blood glucose lowering effect and decreased hypoglycaemia.
Rosak C; Haupt E; Walter T; Werner J
Diabetes Nutr Metab; 2002 Jun; 15(3):143-51. PubMed ID: 12173728
[TBL] [Abstract][Full Text] [Related]
9. Beta cell response to oral glimepiride administration during and following a hyperglycaemic clamp in NIDDM patients.
van der Wal PS; Draeger KE; van Iperen AM; Martini C; Aarsen M; Heine RJ
Diabet Med; 1997 Jul; 14(7):556-63. PubMed ID: 9223393
[TBL] [Abstract][Full Text] [Related]
10. Effect of oral antidiabetic agents on plasma amylin level in patients with non-insulin-dependent diabetes mellitus (type 2).
Zapecka-Dubno B; Czyzyk A; Dworak A; Bak MI
Arzneimittelforschung; 1999 Apr; 49(4):330-4. PubMed ID: 10337452
[TBL] [Abstract][Full Text] [Related]
11. Effect of near physiologic insulin therapy on hypoglycemia counterregulation in type-1 diabetes.
Bischof MG; Bernroider E; Ludwig C; Kurzemann S; Kletter K; Waldhäusl W; Roden M
Horm Res; 2001; 56(5-6):151-8. PubMed ID: 11910200
[TBL] [Abstract][Full Text] [Related]
12. Improved prandial glucose control with lower risk of hypoglycemia with nateglinide than with glibenclamide in patients with maturity-onset diabetes of the young type 3.
Tuomi T; Honkanen EH; Isomaa B; Sarelin L; Groop LC
Diabetes Care; 2006 Feb; 29(2):189-94. PubMed ID: 16443858
[TBL] [Abstract][Full Text] [Related]
13. Effects of glycemic control on protective responses against hypoglycemia in type 2 diabetes.
Korzon-Burakowska A; Hopkins D; Matyka K; Lomas J; Pernet A; Macdonald I; Amiel S
Diabetes Care; 1998 Feb; 21(2):283-90. PubMed ID: 9539997
[TBL] [Abstract][Full Text] [Related]
14. Increased QT dispersion during hypoglycaemia in patients with type 2 diabetes mellitus.
Landstedt-Hallin L; Englund A; Adamson U; Lins PE
J Intern Med; 1999 Sep; 246(3):299-307. PubMed ID: 10475998
[TBL] [Abstract][Full Text] [Related]
15. The insulin secretagogues glibenclamide and repaglinide do not influence growth hormone secretion in humans but stimulate glucagon secretion during profound insulin deficiency.
Østergård T; Degn KB; Gall MA; Carr RD; Veldhuis JD; Thomsen MK; Rizza RA; Schmitz O
J Clin Endocrinol Metab; 2004 Jan; 89(1):297-302. PubMed ID: 14715864
[TBL] [Abstract][Full Text] [Related]
16. Effect of oral amino acids on counterregulatory responses and cognitive function during insulin-induced hypoglycemia in nondiabetic and type 1 diabetic people.
Rossetti P; Porcellati F; Busciantella Ricci N; Candeloro P; Cioli P; Nair KS; Santeusanio F; Bolli GB; Fanelli CG
Diabetes; 2008 Jul; 57(7):1905-17. PubMed ID: 18390791
[TBL] [Abstract][Full Text] [Related]
17. Counterregulatory responses to hypoglycemia differ between glimepiride and glyburide in non diabetic individuals.
Joy NG; Tate DB; Davis SN
Metabolism; 2015 Jun; 64(6):729-37. PubMed ID: 25765720
[TBL] [Abstract][Full Text] [Related]
18. Role of the decrement in intraislet insulin for the glucagon response to hypoglycemia in humans.
Gosmanov NR; Szoke E; Israelian Z; Smith T; Cryer PE; Gerich JE; Meyer C
Diabetes Care; 2005 May; 28(5):1124-31. PubMed ID: 15855577
[TBL] [Abstract][Full Text] [Related]
19. Alcohol and glucose counterregulation during acute insulin-induced hypoglycemia in type 2 diabetic subjects.
Rasmussen BM; Orskov L; Schmitz O; Hermansen K
Metabolism; 2001 Apr; 50(4):451-7. PubMed ID: 11288041
[TBL] [Abstract][Full Text] [Related]
20. Similar physiological and symptomatic responses to sulphonylurea and insulin induced hypoglycaemia in normal subjects.
Peacey SR; George E; Rostami-Hodjegan A; Bedford C; Harris N; Hardisty CA; Tucker GT; Macdonald IA; Heller SR
Diabet Med; 1996 Jul; 13(7):634-41. PubMed ID: 8840097
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
